Seeking Alpha

Shares of MAP Pharmaceuticals (MAPP) soared today, finishing up over +20% after the company...

Shares of MAP Pharmaceuticals (MAPP) soared today, finishing up over +20% after the company announced that the FDA accepted its Levadex resubmission with a six-month review.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)